Shoulder & Elbow
Norepinephrine useful in reducing hypotension & bradycardic events in rotator cuff repair
Arthroscopy. 2015 May;31(5):800-6One hundred and nineteen patients undergoing arthroscopic rotator cuff repair were randomly assigned to a norepinephrine (0.66 mg/L) group or an epinephrine (0.33 mg/L) group to evaluate the efficacy of each treatment. The findings showed that the occurrence rate of hypotensive and bradycardic events (HBEs) was significantly greater in the epinephrine group, but no significant differences were seen between groups in average time of onset of HBEs, accompanying symptoms, and clarity of the visual field.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
